Humana Inc. $HUM Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp decreased its position in Humana Inc. (NYSE:HUM) by 70.6% in the 1st quarter, Holdings Channel.com reports. The firm owned 614,891 shares of the insurance provider’s stock after selling 1,479,679 shares during the period. Bank of New York Mellon Corp’s holdings in Humana were worth $106,616,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently made changes to their positions in the company. Vanguard Group Inc. increased its position in Humana by 0.7% in the 4th quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock valued at $3,652,890,000 after acquiring an additional 106,030 shares during the period. Capital International Investors lifted its holdings in Humana by 113.9% in the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock worth $1,490,239,000 after purchasing an additional 3,097,571 shares during the period. Pzena Investment Management LLC lifted its holdings in Humana by 34.3% in the first quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock worth $948,614,000 after purchasing an additional 1,398,774 shares during the period. State Street Corp grew its position in Humana by 1.8% in the 4th quarter. State Street Corp now owns 5,462,549 shares of the insurance provider’s stock valued at $1,403,877,000 after buying an additional 97,211 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA grew its position in Humana by 28.9% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock valued at $1,151,759,000 after buying an additional 1,008,514 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Trading Down 0.6%

NYSE HUM opened at $397.74 on Tuesday. The firm’s 50 day moving average price is $356.50 and its two-hundred day moving average price is $261.18. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $428.88. The stock has a market cap of $47.75 billion, a price-to-earnings ratio of 42.54, a PEG ratio of 2.16 and a beta of 0.71.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The company had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. During the same quarter in the prior year, the company earned $11.58 earnings per share. The company’s revenue for the quarter was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. Equities analysts anticipate that Humana Inc. will post 9.53 EPS for the current year.

Analyst Ratings Changes

HUM has been the topic of a number of recent analyst reports. Bank of America restated a “neutral” rating and set a $410.00 price target on shares of Humana in a research report on Monday. Needham & Company LLC started coverage on shares of Humana in a research note on Wednesday, May 20th. They set a “buy” rating on the stock. Zacks Research upgraded Humana from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 13th. Seaport Research Partners cut Humana to a “neutral” rating in a research report on Wednesday, May 20th. Finally, William Blair began coverage on Humana in a research note on Wednesday, May 20th. They issued an “outperform” rating on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating, fifteen have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $327.17.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.